Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Swann Dermatology and Esthetics introduces First-Of-Its-Kind Non-Invasive Muscle Toning and Body Shaping Technologies EmSculpt and EmSella to Southwest Missouri
  • USA - English

Revolutionary new technology offers non-invasive treatments for fat and muscle tone and strengthens pelvic floor, core, arms and legs.


News provided by

Swann Dermatology and Esthetics

May 27, 2019, 09:00 ET

Share this article

Share toX

Share this article

Share toX

SPRINGFIELD, Mo., May 27, 2019 /PRNewswire-PRWeb/ -- Dr. Michael Swann, founder and director of Swann Dermatology & Esthetics introduces a groundbreaking new approach to sculpting the body with BTL Emsculpt & Emsella.

EMSCULPT - Emsculpt is the first and only non-invasive body shaping procedure that simultaneously addresses both Muscle and Fat. Bringing an entirely new technology to the category, BTL Emsculpt utilizes HIFEM energy to induce powerful muscle contractions and kill fat cells. FDA-cleared for the improvement of abdominal tone and strengthening of the abdominal muscles, BTL Emsculpt helps patients achieve next-level, contouring results.

"We have seen good success in non-invasive body shaping with CoolSculpting which affects circumferential reduction in fat; however, muscle structure and function has not been a target of prior technologies. Emsculpt is a game-changer.
I'm proud to bring this new paradigm in body shaping to the midwest," said board-certified and fellowship-trained dermatologist Dr. Michael Swann. "Emsculpt causes supramaximal contractions creating 6-pack abs, natural butt lifts, sculpted arms and legs, so I'm thrilled to now offer this combination to my patients," added Dr. Swann.

Muscles represent 35% of the human body, but existing aesthetic treatments only address fat. BTL Emsculpt introduces a first of its kind application of a unique magnetic field. HIFEM technology penetrates through the skin to impact fat, as well as muscle tissues. Once penetrated, the energy induces supramaximal muscle contractions that are accompanied by a rapid metabolic reaction in fat cells to not only strengthen and build muscle, but also breakdown fat. This is the ONLY technology that destroys fat while simultaneously building muscle, all while leaving the surrounding tissues unaffected. Tested in seven clinical studies utilizing MRI, CT and Ultrasound, BTL Emsculpt delivered consistent results with 16% increase in muscle mass, 19% reduction in abdominal fat, average waist reduction of 4.4cm and 91% satisfaction ratings.

EMSELLA - Emsella is a breakthrough technology using HIFEM technology similar to Emsculpt in a chair format to target muscles of the pelvic floor. At least 1 in 4 women have urinary leakage with activity, particularly after childbirth. Emsculpt uses deep electromagnetic stimulation while sitting clothed on a chair to contract the pelvic floor musculature. "One treatment offers the muscular activity of 11,200 kegels. When repeated 6 times over 3 weeks, we see lasting changes in the strength of the pelvic floor that can be sustained with periodic retreatment. For men, bladder position improves and men who wake up at night to urinate are sleeping more soundly" says Dr. Swann. "Pelvic floor weakness and instability is very common and prior treatments were invasive and unnatural. This is a game changer for symptoms of incontinence or sexual dyfunction due to pelvic muscular weakness," adds Dr. Swann.

Dr. Michael Swann is a board certified dermatologist, fellowship-trained in Procedural Dermatology at Scripps Clinic in La Jolla, California under Hubert T. Greenway, MD and E. Vic Ross. He lectures nationally to dermatologists about cutting-edge procedures for skin cancer, reconstructive surgery, laser and cosmetic surgery. Swann Dermatology is a specialized dermatology practice focusing on minimally-invasive approaches with cutting-edge technologies including Mohs surgery, electronic brachytherapy, minimal-incision lifts, Coolsculpting, laser resurfacing, injectables, Ultherapy and esthetician services. The Swann Dermatology Beauty Bar offers walk-in customized skin care directed by Dr. Swann.

For optimal results, Dr. Swann recommends four 30-minute sessions of Emsculpt in 2 weeks with noticeable results in 2 months and improvements for 4 months. Emsculpt costs $650 per session. Emsella gives best pelvic floor results results in six 30-minute sessions over 3 weeks and results are sustained with 2-3 single per year. Initial six-treatment package costs $2000 and single maintenance sessions cost $400.

Media contact: Jasmine Henderson, RN
417-888-0858
jasmine(at)swanndermatology(dot)com

http://www.swanndermatology.com

SOURCE Swann Dermatology and Esthetics

Related Links

http://www.swanndermatology.com

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.